Abstract
Heart disease is one of the common, indirect obstetric causes of maternal death. Management of these cases may challenge the entire team providing care to the mother and fetus. Advances in cardiac surgery has improved quality of life and level of functioning of cardiovascular system of patients with congenital or acquired heart disease. These diseases complicate 0.1–4 % pregnancies. Maternal complications in the form of thromboembolic, hemorrhagic episode and heart failure may occur. The fetus is in danger of effects of oral anticoagulation therapy and other medications given to the patient in order to support cardiovascular system, intrauterine growth restriction and danger of hypoxia. In recent era, we are facing more pregnant patients with previous history of surgical correction of congenital or rheumatic heart disease. In this review, we have attempted to draw a management protocol of such patients based on the available literature and various international guidelines. In pregnant women with mechanical heart valves, recent data support warfarin use throughout pregnancy, followed by a switch to heparin and planned induction of labor. However, the complexity of this situation demands a cafeteria approach where the patient herself can choose from the available options that are supported by evidence-based information. Preconception counseling, evaluation and antenatal high-risk management protocol with the help of cardiologist and cardiac surgeon improves maternal and neonatal outcome.
Similar content being viewed by others
Abbreviations
- AHA:
-
American Heart Association
- ACCP:
-
American College of Chest Physicians
- ESC:
-
European Society of Cardiology
- INR:
-
International normalized ratio
- LMWH:
-
Low molecular weight heparin
- UFH:
-
Unfractionated heparin
- OAC:
-
Oral anticoagulants
References
Royal College of Obstetricians and Gynaecologists. Why mothers die 2000–2002—the sixth report of confidential enquiries into maternal deaths in the United Kingdom. London: RCOG press; 2004.
Plesinac S, Pilic I. Course and outcome of pregnancy after the heart surgery. In: Proceedings of the world medical conference Prague. September 2011.
Srivastava AP, Modi P, Sahi S, et al. Anticoagulation for pregnant patients. Ann Card Anesth. 2007;10:95–107.
Elkayam U, Bitar F. Valvular heart disease and pregnancy part II: prosthetic valves. J Am Coll Cardiol. 2005;46(3):403–10. doi:10.1016/j.jacc.2005.02.087.
European Society of Gynecology (ESG), Association for European Pediatrics Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC guidelines on the management of cardiovascular diseases during pregnancy: the task force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:3147.
Hirsh J, Dalen JE, Deykin D et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. In: Fourth ACCP consensus conference on antithrombotic therapy. Chest. 1995; 108(suppl):231S–246S.
Hung L, Rahimtoola SH. Prosthetic heart valves and pregnancy clinical update. Circulation. 2003;107:1240–6.
Castellano JM, Narayan RL, Vaishnava P, et al. Anticoagulation during pregnancy in patients with a prosthetic heart valve. Nat Rev Cardiol. 2012;9:415–24. doi:10.1038/nrcardio.2012.69.
James A. Committee on practice bulletins—obstetrics. Thromboembolism Pregnancy Obstet Gynecol. 2011;118(3):718–29. doi:10.1097/AOG.0b013e3182310c4c.
Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:e57.
Starling LD. Fetal warfarin syndrome. BMJ Case Reports http://casereports.bmj.com/content/2012/bcr-2012-007344.
Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systemic review of the literature. Arch Intern Med. 2000;160:191–6.
Sorin C. Juverdeanu surgical termination of pregnancy for maternal cardiac disease: a safer option? TMJ. 2009;59(2):169–72.
Ray P, Murphy GJ. Recognition and management of maternal cardiac disease in pregnancy. Br J Anaesth. 2004;93(3):428–39.
Gary M, Harrison J. Analysis of severe adverse events related to the use of mifepristone as an abortifacient. Ann Pharmacother. 2006;40(2):191–7.
Bonow RO, Carabello BA, Chatterjee K et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118(15):e523–661.
Gopalakrishnan S, Narayanan S. Oral anticoagulants: current Indian scenario. In: Medicine update. The Association of Physicians of India; 2013. p. 410–3.
Sibai BM. Effects of diuretics on plasma volume in pregnancies with long-term hypertension. Am J Obstet Gynecol. 1984;150(7):831–5.
North RA, Hunt B, Gaasch WH et al. Management of pregnant women with prosthetic heart valves, 2015.
Silversides CK. Choosing the best contraceptive method for the adult with congenital heart disease. Curr Cardiol Rep. 2009;11:298–305.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author has no conflict of interest.
Additional information
Anjali Vivek Kanhere, MBBS, MD, FICOG FAIMER Fellow (GSMC Mumbai 2011), is a Professor and Head of Department, Department of Obstetrics and Gynecology at Chirayu Medical College and Hospital, Bhopal. Vivek Madhav Kanhere, MBBS, MS, MCh (Cardiothoracic Surgery), is a Consultant and Assistant Professor in Department of Cardiothoracic Surgery at Chirayu Cardiac Center, Chirayu Medical College and Hospital, Bhopal.
Rights and permissions
About this article
Cite this article
Kanhere, A.V., Kanhere, V.M. Pregnancy After Cardiac Surgery. J Obstet Gynecol India 66, 10–15 (2016). https://doi.org/10.1007/s13224-016-0841-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13224-016-0841-y